medigraphic.com
ISSN 1561-302X (Print)

2014, Number 3

<< Back Next >>

Rev cubana med 2014; 53 (3)

Acquired renal cystic disease and its relationship to clinical, demographic and anthropometric variables in patients on hemodialysis

Bacallao MRA, Ávila GA, Salgado LJ, Gutiérrez GF, Llerena FB

Language: Spanish
References: 22
Page: 291-299
PDF size: 135.68 Kb.


ABSTRACT

Introduction: chronic kidney disease (CKD) is frequently associated with acquired renal cystic disease (ARCD). The latter condition is usually clinically asymptomatic, but it may complicate with renal carcinoma.
Objective: identify the frequency of presentation of ARCD and the possible relationship of renal length and the number and size of cysts, to characteristics of patients on hemodialysis.
Methods: an analytical cross-sectional study was conducted of all the patients on hemodialysis at the Institute of Nephrology in June 2012. Patients with cystic disease as the cause of CKD, nephrectomized patients and those with a poor echographic window were not included. Renal echography was performed with high resolution Toshiba Nemio XG equipment and a 3.5 MHz convex transducer. Data was processed with the statistical software SPSS version 15.0. The Wilcoxon-Mann- Whitney and Kruskal-Wallis tests were used for identification of the possible relationships between variables. The Pearson linear correlation coefficient (r) was also used.
Results: 38.4 % of the patients had ARCD. An association was found between the number of cysts and the time on hemodialysis, the doses of erythropoietin used, and hemoglobin values (p ‹ 0.05 in the three cases). The relationship between time on hemodialysis and number of cysts was direct and moderate (r= 0.60).
Conclusions: the frequency of ARCD was high among patients on hemodialysis. The number of cysts increased with treatment time. Patients with a greater number of cysts have higher hemoglobin values and require smaller doses of erythropoietin.


REFERENCES

  1. Bonsib SM. Renal cystic diseases and renal neoplasms: a mini-review. Clin J Am Soc Nephrol. Dic. 2009;4(12):1998-2007.

  2. Blagg CR. Acquired Renal Cystic disease. Saudi J Kidney Dis Transplant. 1997;8(2):105-12.

  3. Chapman AB, Rahbari-Oskoui FF, Bennett WM. Acquired cystic disease of the kidney in adults. UpToDate [serie en internet] 2013 [citado 12 Mar 2013]. Disponible en: http://www.uptodate.com/contents/acquired-cystic-disease-of-thekidney- in-adults

  4. Hussain S, Khan SA, Dodhy KA, Khan FA. Sonographic prevalence of acquired cystic renal disease in patients receiving haemodialysis. J Pak Med Assoc. 2003;53:111-3.

  5. Acquired cystic kidney disease in children undergoing continuous ambulatory peritoneal dialysis. Kyushu Pediatric Nephrology Study Group. Am J Kidney Dis. 1999;34:242.

  6. Gnionsahe DA, Lagou DA, Tia WM. Prevalence of acquired cystic disease in black Africans on hemodialysis in West Africa. Saudi J Kidney Dis Transpl. 2007;18:114.

  7. Grantham JJ. Acquired cystic kidney disease. Kidney Int. 1991;40:143.

  8. Moch H. Cystic renal tumors: new entities and novel concepts. Adv Anat Pathol. May. 2010;17(3):209-14.

  9. Ahn S, Kwon GY, Cho YM, Jun SY, Choi C, Kim HJ, et al. Acquired cystic diseaseassociated renal cell carcinoma: further characterization of the morphologic and immunopathologic features. Med Mol Morphol. Dic. 2013;46(4):225-32.

  10. Moore AE, Kujubu DA. Spontaneous retroperitoneal hemorrhage due to acquired cystic kidney disease. Hemodial Int. 2007;11(Suppl 3):S38.

  11. Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes. 1985;9:147-53.

  12. Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916,17:862.

  13. Pérez-Oliva J, Pérez R, Herrera R, Almaguer M, Brisquet E. Terapia renal de reemplazo dialítico en Cuba: tendencia durante los últimos 10 años. Rev Hab Cienc Méd. 2012;11(3):424-33.

  14. Oyuela-Carrasco J, Rodríguez-Castellanos F, Kimura E, Delgado-Hernández R, Herrera-Félix JP. Longitud renal por ultrasonografía en población mexicana adulta. Nefrología. 2009;29(1):30-4.

  15. Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol. 1977;30:868-77.

  16. Correas JM, Joly D, Chauveau D, Richard S, Hélénon O. Renal failure and cystic kidney diseases. J Radiol. Abr. 2011;92(4):308-22.

  17. Beladi Mousavi SS, Sametzadeh M, Hayati F, Fatemi SM. Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography. Iran J Kidney Dis. Jul. 2010;4(3):223-6.

  18. Ishikawa I, Hayama S, Morita K, Nakazawa T, Yokoyama H, Honda R, et al. Long-term natural history of acquired cystic disease of the kidney. Ther Apher Dial. 1 Ag. 2010;14(4):409-16.

  19. Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. C-jun activation in acquired cystic kidney disease and renal cell carcinoma. J Urol. 2005;174:726.

  20. Banerji JS, Singh SK, Kekre NS. Renal cell carcinoma in acquired renal cystic disease following renal transplantation. ANZ J Surg. En. 2014;84(1-2):91-2.

  21. Narasimhan N, Golper TA, Wolfson M, Rahatzad M, Bennett WM. Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int. 1986;30:748-52.

  22. Fernández A, Horta L, Rodríguez JC, Vega N, Plaza C, Palop L. Anemia in dialysis its relatio to acquired cystic kidney disease and serum levels of erythropoietin. Am J Nephrol. 1991;11:12-5.




2020     |     www.medigraphic.com